Steady Meds reviews
Steady Meds reviews: 23 independent lab tests across 3 products, with a mixed lab record.
Written by the Peptide Vendor Reviews editorial team
Is Steady Meds legit? Lab record: Mixed
How we rate- 23 independent tests
- 9 of 18 lots filled to label
- Median purity 99.9%
- 1 of 3 products graded D or E
Some of Steady Meds's products graded D or E. The shops below tested A or B for the same peptides.
Better-tested GHK-Cu
Steady Meds graded D. Verified Peptides's GHK-Cu graded A across 3 tests, $0.45 / mg.
Buy from Verified PeptidesAll better-tested optionsPeptide Vendor Reviews independently tests products and verifies reviews. Public methodology, no pay-to-rank.
Better-tested options
Where Steady Meds graded D or E, these shops' samples of the same peptide graded A or B. Ordered by grade, then price per mg. Partner status never changes the order.
GHK-Cu
Steady Meds: grade DSteady Meds products we've tested
Best-graded first. Grades come from the share of each product's samples that passed purity and quantity checks. Buy links open Steady Meds' site.
- RetatrutideBGOOD
- Tests
- 10
- Passed
- 80.0%
- TirzepatideCOKAY
- Tests
- 7
- Passed
- 71.4%
- GHK-CuDPOOR
- Tests
- 6
- Passed
- 66.7%
What the testing shows
Across 18 measured samples from Steady Meds, 9 came in more than 5% under the quantity on the label (50%). Another 4 measured more than 5% over. Purity across 19 readings ran from 99.5% to 99.9%, median 99.9%. Samples span Jan 2026 to Sep 2026.
- Under label
- 9/18
- Median purity
- 99.9%
- Latest sample
- Sep 2026
more than 5% short
99.5%–99.9% range
first tested Jan 2026
Our read on Steady Meds
17 of Steady Meds' 23 graded samples passed (74%), and 100% of all samples were sent in by buyers rather than by the shop.
Results are slipping: 38% passed over the latest six months, down from 93% before.
When a sample failed, the most common reason was the lab could not confirm it was the labelled peptide (4 times).
Against the 302 shops with at least five graded tests, Steady Meds' pass rate is at or above 56% of them, and it has more tests on record than 56% of them.
When and how Steady Meds was tested
Samples per month. The darker part of each bar failed.
- Labs used
- Krause Analytical (16), BTLabs (7)
- Who sent the samples
- buyers 100%
- Batches covered
- 4 distinct batch numbers; 3 checked for endotoxins
Why Steady Meds' failed samples failed
The 6 most recent failed tests, with the lab's reason.
GHK-Cu · Sep 24, 2026
amount in the vial more than 35% off the label
Tirzepatide · Sep 24, 2026
the lab could not confirm it was the labelled peptide
Tirzepatide · Aug 4, 2026
the lab could not confirm it was the labelled peptide
Retatrutide · Aug 4, 2026
the lab could not confirm it was the labelled peptide
GHK-Cu · Aug 4, 2026
amount in the vial more than 35% off the label
Retatrutide · Mar 13, 2026
the lab could not confirm it was the labelled peptide
Lab testing results
Independent results across 3 products.
Individual lab tests
Date
9/24/2026
Purity
—
Quantity
—
Lab
BTLabs
Vial
No label / Silver crimp / White cap
Date
9/24/2026
Purity
99.7%
Quantity
100 mg → 45.4 mg
Lab
BTLabs
Vial
No label / Silver crimp / Blue cap
Date
9/16/2026
Purity
99.6%
Quantity
100 mg → 78.5 mg
Lab
BTLabs
Vial
Silver label / Silver crimp / Red cap
Date
9/16/2026
Purity
99.9%
Quantity
60 mg → 65.6 mg
Lab
BTLabs
Vial
Silver label / Silver crimp / Orange cap
Date
8/31/2026
Purity
99.8%
Quantity
60 mg → 66.4 mg
Lab
BTLabs
Vial
White label / Silver crimp / Red cap
| Product | Date | Score | Purity | Quantity | Lab | COA |
|---|---|---|---|---|---|---|
| TirzepatideNo label / Silver crimp / White cap | 9/24/2026 | — | — | BTLabs | View | |
| GHK-CuNo label / Silver crimp / Blue cap | 9/24/2026 | 10.0 | 99.7% | 100 mg → 45.4 mg | BTLabs | View |
| GHK-CuSilver label / Silver crimp / Red cap | 9/16/2026 | 10.0 | 99.6% | 100 mg → 78.5 mg | BTLabs | View |
| RetatrutideSilver label / Silver crimp / Orange cap | 9/16/2026 | 10.0 | 99.9% | 60 mg → 65.6 mg | BTLabs | View |
| TirzepatideWhite label / Silver crimp / Red cap | 8/31/2026 | 10.0 | 99.8% | 60 mg → 66.4 mg | BTLabs | View |
Which Steady Meds products tested best
Retatrutide has the strongest record, graded A or B.
Tirzepatide graded C.
GHK-Cu graded D or E: a large share of its samples missed purity or quantity thresholds.
Buying from Steady Meds
If you order from Steady Meds, the A- and B-graded products are the safer picks on this record. For the weaker ones, the better-tested options on this page come from other shops.
We don't track Steady Meds' prices yet. Shipping, payment and refund terms are on their site.
The official store is steadymeds.com. Check the address before you pay.
What to check before you pay
- The lot number on the vial matches the certificate
- The certificate names the lab and the test date
- Fill versus label, not purity alone
- A refund policy in writing
Track Steady Meds
Create a free account to save this vendor, get alerts for new lab tests, and watch price changes.
Steady Meds: common questions
Is Steady Meds legit?
We rate lab records, not businesses. Mixed lab record: 23 independent tests, 9 of 18 lots filled to label, median purity 99.9%, 1 of 3 products graded D or E. Each result links to its original certificate in the table above.
What do Steady Meds reviews say?
We don't hold scored customer reviews for Steady Meds yet. The independent lab results on this page are the evidence we have.
Which Steady Meds peptides tested best?
We have graded 3 Steady Meds products. Retatrutide graded A or B. GHK-Cu graded D or E.
Is there a Steady Meds coupon code?
We don't have a verified Steady Meds coupon code. A discount changes the price, not what is in the vial.
Ordering from Steady Meds?
Mixed lab record: 23 independent tests, 9 of 18 lots filled to label, median purity 99.9%, 1 of 3 products graded D or E.